课题基金 / 基金详情

Development of a novel therapy for severe acute pancreatitis by a specific inhibiiton of NF-κB- -Basic analysis using recombinant NLS-I k Bαadenoviral vector-

Development of a novel therapy for severe acute pancreatitis by a specific inhibiiton of NF-κB- -Basic analysis using recombinant NLS-I k Bαadenoviral vector-
通过特异性抑制NF-κB开发重症急性胰腺炎新疗法- -使用重组NLS-I k Bα腺病毒载体进行基础分析-
批准号:
11670472
负责人:
SHIMOSEGAWA Tooru
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

SHIMOSEGAWA Tooru的其他基金

相似基金

相关文献

中文摘要
翻译
1999年,我们成功地将IκBα cDNA与核定位信号结合,构建了重组NLS-I κ Bα腺病毒载体。然而,IκBα和SV 40大T抗原的cDNA很难获得精确的核苷酸序列。我们还研究了cDNA构建体是否可以整合到腺病毒载体中,但也难以获得满意的结果。因此,我们在体内研究了NF-κB抑制剂如PDTC或NAC是否能减轻致死性胰腺炎(TCA胰腺炎)和非致死性水肿性胰腺炎(Cn胰腺炎)大鼠肺损伤模型中的肺损伤。PDTC或NAC预处理均能明显改善肺损伤,提高大鼠存活率。认为这种作用至少是通过阻断NF-κB活化抑制肺中TNA-α和IL-1 β的产生而产生的。2000年和2001年,我们继续生产重组NLS-I-κBα腺病毒载体。此外,我们还检测并证实了PAAF中的某些因子可以直接刺激血管内皮细胞或单核细胞,并在体外上调这些细胞中粘附分子和各种细胞因子的表达。我们还证实了抑制NF-κB可以阻断这些促炎分子的表达。
英文摘要
In 1999, we have to decelop a recombinant NLS-IκBα adenoviral vector in which IκBα cDNA was bound to a nuclear localizing signal. However, it was difficult to produce the cDNAs of IκBα and SV40 large T antigen with precise nudiotide sequences. We have also examined whether cDNA construct could be incorporated into the adenoviral vector or not, but it was also difficult to obtain satisfatory results. Therefore, we have studied in vivo whether the NF-κB inhibitors such as PDTC) or NAC could alleviate the lung injury in a model of lethal pancreatitis (TCA pancreatitis) and in a model with lung injury which was induced by a trasfer of the supematant of TCA pancreatitis ascites (P-AAF) into the rats with nonlethal edematous pancreatitis (Cn pancreatitis). In both models pretreatment with PDTC or NAC improved significantly the lung injury, and the survival of these rats was improved. The effects were considered to be brought about at least by the inhibition of TNA-α and lL-1 β production in the lung via a blockade of NF-κB activation. In 2000 and 2OO1, we have continued to produce the recombinant NLS-I-κBα adenoviral vector. Additionally, we have examined and verified the preset of some factors in the PAAF that could stimulate directly vascular endothelial cells or mono cytes and upregulate the expression of adhesion molecules and various cytoldnes in vitro in these cells. We have also confirmed that an inhibition of NF-κB could block the expression of these proinflammatory molecules.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
正宗 淳: "Expression of survivin is correlated with cancer cell apoptuims and is involved in the development of human pancreafic duet"cancer. 92. 271-278 (2001)
Jun Masamune:“生存素的表达与癌细胞凋亡相关,并参与人类胰腺二重奏的发展”癌症。 92. 271-278 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
下瀬川 徹: "急性膵炎重症化の機序"日本消化器病学会誌. 98. 1029-1036 (2001)
下濑川彻:《急性胰腺炎恶化的机制》日本消化器学会杂志 98. 1029-1036 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T, Shimosegawa, at al: "Specific induction of adhesion molecules in human vascular endothelial Cells by rat experimental pancreatitis-associated"Pancreas. 18. 141-150 (2000)
T,Shimosekawa 等人:“大鼠实验性胰腺炎相关的胰腺对人血管内皮细胞中粘附分子的特异性诱导”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
正宗 淳: "Expression of survirin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct"Cancer. 92. 271-278 (2001)
Jun Masamune:“survirin 的表达与癌细胞凋亡相关,并参与人胰管的发育”Cancer. 92. 271-278 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 26 条
    Analysis of pancreatitis-associated gene variation by next-generation sequencing
    • 批准号:
      25670363
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2013
    • 负责人:
      SHIMOSEGAWA Tooru
    • 依托单位:
    Novel therapeutic strategy targeting pancreatic cancer stem cell-niche
    • 批准号:
      23390194
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2011
    • 负责人:
      SHIMOSEGAWA Tooru
    • 依托单位:
    Analysis of pancreatitis-associated genetic disorders by whole exome sequencing
    • 批准号:
      23659392
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      SHIMOSEGAWA Tooru
    • 依托单位:
    Elucidation of regeneration-mechanisms through notch signaling and establishment of novel stem cell transplantation in pancreas
    • 批准号:
      14370172
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      2002
    • 负责人:
      SHIMOSEGAWA Tooru
    • 依托单位:
    国内基金
    海外基金
    苏木酮A介导NLRX1调控TRAF6/NF-κB抑制破骨细胞分化缓解骨质疏松症的机制研究
    • 批准号:
      2026JJ82705
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘中
    • 依托单位:
    干葛散调控TLR4/MyD88/NF-κB轴改善HaCat细胞炎症反应治疗特应性皮炎作用机制研究
    • 批准号:
      2026JJ81892
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张小娟
    • 依托单位:
    基于TLR4/P38MAPK/NF-ΚB通路的栀子苷和大黄素配伍抗脓毒症肠屏障炎性损伤研究
    辣椒平调控NF-κB/NLRP3 炎症小体通路在快速进展型尘肺中的作用
    • 批准号:
      2026JJ81460
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈柔
    • 依托单位: